Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - GeneralUpdated 2026-05-10 22:07 UTC

KOSDAQ/039200 stock hub

KOSDAQ/039200 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

KOSDAQ/039200is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2T
KOSDAQ
Market data

Live price

Current market quote for this ticker.

Current price
KOSDAQ/039200
In the news

Latest news · KOSDAQ/039200

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E60.6
P25 9.8P50 17.1P75 31.9
Trailing P/E37.3
P25 12P50 23.1P75 39.5
ROE34.1
P25 -17.1P50 0.7P75 8.5
ROIC84.5
P25 -9P50 1.3P75 6.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All KOSDAQ/039200 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
210
Groups with data
11
Currency
KRW
Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
South Korea
Country code
KR
Employees
53
Enterprise value
KRW 1.9T
Exchange
KOSDAQ
Financial currency
KRW
First seen
2026-05-10
Industry
Drug Manufacturers - General
Isin
KR7039200001
Last refreshed
2026-05-10
Market cap
KRW 2T
Price
KRW 51,000
Price currency
KRW
Rev Per Employee
1,883,748,475.85x
Sector
Healthcare
Sic
3842
Symbol
kosdaq/039200
Website
https://oscotec.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

11
MetricValue
Earnings Yield
2.68%
EV Earnings
35.62x
EV/EBIT
35.79x
EV/EBITDA
34.7x
EV/FCF
247.81x
EV/Sales
18.67x
FCF yield
0.39%
Forward P/E
60.64x
P/B ratio
10.44x
P/E ratio
37.28x
P/S ratio
19.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
52.17%
EBITDA Margin
53.82%
FCF margin
7.53%
Gross margin
97.84%
Gross Profit
KRW 97.7B
Gross Profit Growth
210.75%
Gross Profit Growth Q
4,757.97%
Gross Profit Growth3 Y
225.26%
Gross Profit Growth5 Y
18.72%
Net Income
KRW 52.3B
Net Income Growth
5,871.65%
Net Income Growth Quarters
1%
Net Income Growth Years
4%
Pretax Margin
52.87%
Profit Margin
52.43%
Profit Per Employee
KRW 987.6M
Profitable Years
2
ROA
16.25
Roa5y
-9.25
ROCE
27.29
ROE
34.08
Roe5y
-18.92
ROIC
84.51
Roic5y
-55.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

15
MetricValue
Cagr10y
19.36%
Cagr15y
22.98%
Cagr1y
92.54%
Cagr3y
31.94%
Cagr5y
7.32%
EPS Growth
5,868.9
EPS Growth Quarters
1
EPS Growth Years
4
OCF Growth10 Y
29.1%
Revenue Growth
193.58x
Revenue Growth Q
3,279.27x
Revenue Growth Quarters
1x
Revenue Growth Years
2x
Revenue Growth3 Y
170.18x
Revenue Growth5 Y
18.09x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

23
MetricValue
Asset Turnover
KRW 0.5
Assets
KRW 229.9B
Cash
KRW 108.1B
Current Assets
KRW 199B
Current Liabilities
KRW 39B
Debt
KRW 15.6B
Debt EBITDA
KRW 0.29
Debt Equity
KRW 0.08
Debt FCF
KRW 2.08
Equity
KRW 186.8B
Interest Coverage
22.96
Liabilities
KRW 43B
Long Term Assets
KRW 30.9B
Long Term Liabilities
KRW 4B
Net Cash
KRW 92.5B
Net Cash By Market Cap
KRW 4.74
Net Cash Growth
4%
Net Debt EBITDA
KRW -1.72
Net Debt Equity
KRW -0.49
Net Debt FCF
KRW -12.29
Tangible Book Value
KRW 180.8B
Tangible Book Value Per Share
KRW 4,725
WACC
10.68

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
5.1
Inventory Turnover
1.2
Net Working Capital
KRW 67.5B
Quick ratio
5.02
Working Capital
KRW 160B
Working Capital Turnover
KRW 0.75

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
-0.02%
Dividend per share
KRW 0
Last Dividend
KRW 12.5

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
486.53%
1Y total return
92.45%
200-day SMA
46,412.5
3Y total return
129.73%
50-day SMA
52,405
50-day SMA vs 200-day SMA
50over200
5Y total return
42.33%
All Time High
71,500
All Time High Change
-28.67%
All Time High Date
2020-12-08
All Time Low
1,315
All Time Low Change
3,778.33%
All Time Low Date
2013-06-25
ATR
2,934.7
Beta
1.17
Beta1y
0.49
Beta2y
0.46
Ch YTD
12.83
High
51,700
High52
66,000
High52 Date
2025-12-16
High52ch
-22.73%
Low
48,800
Low52
25,000
Low52 Date
2025-05-12
Low52ch
104%
Ma50ch
-2.68%
Price vs 200-day SMA
9.88%
RSI
47.34
RSI Monthly
58.49
RSI Weekly
51.89
Sharpe ratio
1.05x
Sortino ratio
1.84
Total Return
-0.02%
Tr YTD
12.83
Tr15y
2,125.96%
Tr1m
7.82%
Tr1w
-0.78%
Tr3m
-2.49%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

3
MetricValue
Operating Income
KRW 52.1B
Operating Income Growth5 Y
101.3
Operating margin
52.17

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
33,405,772%
Net Borrowing
-137,541,960
Shares Insiders
12.68%
Shares Institutions
21.86%
Shares Out
38,258,176
Shares Qo Q
0.01%
Shares Yo Y
0.02%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

61
MetricValue
Adjusted FCF
KRW 7B
Average Volume
232,018.35x
Bv Per Share
4,739.1
CAPEX
KRW -779.6M
Ch10y
460.4
Ch15y
1,861.5
Ch1m
7.82
Ch1w
-0.78
Ch1y
92.45
Ch3m
-2.49
Ch3y
129.7
Ch5y
36
Ch6m
9.44
Change
3.87%
Change From Open
2.2
Close
49,100
Days Gap
1.63
Depreciation Amortization
1,648,326,240
Dollar Volume
14,014,035,000
Earnings Date
2026-05-12
EBIT
KRW 52.1B
EBITDA
KRW 53.7B
EPS
KRW 1,368
F Score
6
FCF
KRW 7.5B
FCF EV Yield
0.4x
FCF Per Share
KRW 197
Financing CF
-1,852,239,240
Fiscal Year End
December
Founded
1,998
Graham Number
12077.58084
Graham Upside
-76.32
Income Tax
KRW -1.6B
Investing CF
-4,082,071,850
Is Primary Listing
1
Last Earnings Date
2025-11-14
Last Report Date
2025-12-31
Last Split Date
2009-12-29
Last Split Type
Forward
Ma150
49,956.7
Ma150ch
2.09%
Ma20
52,825
Ma20ch
-3.45%
Net CF
2,085,941,820
Next Earnings Date
2026-05-12
Open
49,900
P FCF Ratio
259.4
P OCF Ratio
235
Position In Range
75.86
Ppne
19,189,921,000
Price Date
2026-05-08
Price EBITDA
KRW 36.31
Ptbv Ratio
10.79
Relative Volume
1.17x
Revenue
99,838,669,220x
SBC By Revenue
0.55x
Share Based Comp
546,294,610
Tax By Revenue
-1.61x
Tr6m
9.44%
Volume
274,785
Z Score
20.38
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does KOSDAQ/039200 pay a dividend?

Capital-return profile for this ticker.

Performance

KOSDAQ/039200 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+92.5%
S&P 500 1Y: n/a
3Y total return
+129.7%
S&P 500 3Y: n/a
5Y total return
+42.3%
S&P 500 5Y: n/a
10Y total return
+486.5%
S&P 500 10Y: n/a
Ownership

Who owns KOSDAQ/039200?

Insider, institutional, and short-interest positioning.

Institutional ownership
+21.9%
Share of float held by funds and institutions
Insider ownership
+12.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.0%
Negative means the company is buying back shares.
Technical

KOSDAQ/039200 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
47.3
Neutral momentum band
Price vs 200-day MA
+9.9%
50/200-day relationship not available
Beta (5Y)
1.17
Moves roughly with the market
Sharpe ratio
1.05
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About KOSDAQ/039200

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/039200 stock rating?

kosdaq/039200 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/039200 analysis?

The full report lives at /stocks/kosdaq/039200/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/039200?

The latest report frames kosdaq/039200 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/039200 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.